Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 697972, 10 pages
http://dx.doi.org/10.1155/2013/697972
Research Article

Monocytes, Peripheral Blood Mononuclear Cells, and THP-1 Cells Exhibit Different Cytokine Expression Patterns following Stimulation with Lipopolysaccharide

1Department for Health Sciences and Biomedicine, Center for Biomedical Technology, Danube University Krems, Dr.-Karl-Dorrek-Straße 30, 3500 Krems, Austria
2Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis, Danube University Krems, Dr.-Karl-Dorrek-Straße 30, 3500 Krems, Austria

Received 8 February 2013; Revised 23 March 2013; Accepted 25 March 2013

Academic Editor: Eduardo López-Collazo

Copyright © 2013 Anita Schildberger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. C. Aird, “Phenotypic heterogeneity of the endothelium—I. Structure, function, and mechanisms,” Circulation Research, vol. 100, no. 2, pp. 158–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Pober and W. C. Sessa, “Evolving functions of endothelial cells in inflammation,” Nature Reviews Immunology, vol. 7, no. 10, pp. 803–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. C. E. Hack, S. Zeerleder, J. F. Dhainaut, F. Taylor, and K. Reinhart, “The endothelium in sepsis: source of and a target for inflammation,” Critical Care Medicine, vol. 29, no. 7, pp. S21–S27, 2001. View at Google Scholar · View at Scopus
  4. N. Matsuda and Y. Hattori, “Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction,” Journal of Smooth Muscle Research, vol. 43, no. 4, pp. 117–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. W. C. Aird, “Endothelium in health and disease,” Pharmacological Reports, vol. 60, no. 1, pp. 139–143, 2008. View at Google Scholar · View at Scopus
  6. M. M. Levy, M. P. Fink, J. C. Marshall et al., “2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference,” Critical Care Medicine, vol. 31, no. 4, pp. 1250–1256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Rittirsch, M. A. Flierl, and P. A. Ward, “Harmful molecular mechanisms in sepsis,” Nature Reviews Immunology, vol. 8, no. 10, pp. 776–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. G. M. Pittoni and A. Scatto, “Economics and outcome in the intensive care unit,” Current Opinion in Anaesthesiology, vol. 22, no. 2, pp. 232–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Hotchkiss and I. E. Karl, “The pathophysiology and treatment of sepsis,” New England Journal of Medicine, vol. 348, no. 2, pp. 138–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Panagiotou, S. Gaiao, and D. N. Cruz, “Extracorporeal therapies in sepsis,” Journal of Intensive Care Medicine, 2011. View at Google Scholar
  11. Z. Y. Peng, H. Z. Wang, M. J. Carter et al., “Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis,” Kidney International, vol. 81, pp. 363–369, 2012. View at Google Scholar
  12. A. Schildberger, E. Rossmanith, V. Weber, and D. Falkenhagen, “Monitoring of endothelial cell activation in experimental sepsis with a two-step cell culture model,” Innate Immunity, vol. 16, no. 5, pp. 278–287, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Schildberger, T. Buchacher, V. Weber, and D. Falkenhagen, “Adsorptive modulation of inflammatory mediators dampens endothelial cell activation,” Blood Purification, vol. 32, pp. 286–295, 2011. View at Google Scholar
  14. O. Sharif, V. N. Bolshakov, S. Raines, P. Newham, and N. D. Perkins, “Transcriptional profiling of the LPS induced NF-κB response in macrophages,” BMC Immunology, vol. 8, article 1, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Kellum, M. Song, and R. Venkataraman, “Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-κB DNA binding, and improves short-term survival in lethal endotoxemia,” Critical Care Medicine, vol. 32, no. 3, pp. 801–805, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Tetta, J. M. Cavaillon, M. Schulze et al., “Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption,” Nephrology Dialysis Transplantation, vol. 13, no. 6, pp. 1458–1464, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Cantaluppi, V. Weber, C. Lauritano et al., “Protective effect of resin adsorption on septic plasma-induced tubular injury,” Critical Care, vol. 14, no. 1, article R4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Qin, “The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature,” Atherosclerosis, vol. 221, pp. 2–11, 2012. View at Google Scholar
  19. D. C. Altieri and T. S. Edgington, “The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor,” Journal of Biological Chemistry, vol. 263, no. 15, pp. 7007–7015, 1988. View at Google Scholar · View at Scopus
  20. G. Kaplanski, V. Marin, M. Fabrigoule et al., “Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106),” Blood, vol. 92, no. 4, pp. 1259–1267, 1998. View at Google Scholar · View at Scopus
  21. T. Krakauer, “A sensitive ELISA for measuring the adhesion of leukocytic cells to human endothelial cells,” Journal of Immunological Methods, vol. 177, no. 1-2, pp. 207–213, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. A. A. Sneddon, E. McLeod, K. W. J. Wahle, and J. R. Arthur, “Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid,” Biochimica et Biophysica Acta, vol. 1761, no. 7, pp. 793–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Reinhart, M. Meisner, and F. M. Brunkhorst, “Markers for sepsis diagnosis: what is useful?” Critical Care Clinics, vol. 22, no. 3, pp. 503–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. R. Palacio, U. R. Markert, and P. Martinez, “Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages,” Inflammation Research, vol. 60, pp. 695–704, 2011. View at Google Scholar
  25. J. Wehrhahn, R. Kraft, C. Harteneck, and S. Hauschildt, “Transient receptor potential melastatin 2 is required for lipopolysaccharide-induced cytokine production in human monocytes,” Journal of Immunology, vol. 184, no. 5, pp. 2386–2393, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Dehus, T. Hartung, and C. Hermann, “Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay,” Journal of Endotoxin Research, vol. 12, no. 3, pp. 171–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Schwanzer-Pfeiffer, E. Roßmanith, A. Schildberger, and D. Falkenhagen, “Characterization of SVEP1, KIAA, and SRPX2 in an in vitro cell culture model of endotoxemia,” Cellular Immunology, vol. 263, no. 1, pp. 65–70, 2010. View at Publisher · View at Google Scholar · View at Scopus